Early Predictors of Renal Dysfunction in Egyptian Patients with β-Thalassemia Major and Intermedia

por Tantawy, Azza A.G., El Bablawy, Nagham, Adly, Amira A.M., Ebeid, Fatma S.E.
Publicado 2014

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study

por Kwiatkowski, Janet L., Hamdy, Mona, El-Beshlawy, Amal, Ebeid, Fatma S. E., Badr, Mohammed, Alshehri, Abdulrahman, Kanter, Julie, Inusa, Baba, Adly, Amira A. M., Williams, Suzan, Kilinc, Yurdanur, Lee, David, Tricta, Fernando, Elalfy, Mohsen S.
Publicado 2022

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years

por Elalfy, Mohsen S., Hamdy, Mona, El-Beshlawy, Amal, Ebeid, Fatma S. E., Badr, Mohamed, Kanter, Julie, Inusa, Baba, Adly, Amira A. M., Williams, Suzan, Kilinc, Yurdanur, Lee, David, Fradette, Caroline, Rozova, Anna, Temin, Noemi Toiber, Tricta, Fernando, Kwiatkowski, Janet L.
Publicado 2022